The estimated Net Worth of Kyle Lefkoff is at least $2.45 Million dollars as of 6 February 2019. Kyle Lefkoff owns over 35,000 units of Miragen Therapeutics Inc stock worth over $460,200 and over the last 21 years Kyle sold MGEN stock worth over $1,989,730.
Sign up
Kyle Lefkoff MGEN stock SEC Form 4 insiders trading
Kyle has made over 19 trades of the Miragen Therapeutics Inc stock since 2006, according to the Form 4 filled with the SEC. Most recently Kyle sold 35,000 units of MGEN stock worth $721,000 on 6 February 2019.
The largest trade Kyle's ever made was exercising 70,000 units of Miragen Therapeutics Inc stock on 3 March 2015 worth over $196,000. On average, Kyle trades about 12,675 units every 139 days since 2003. As of 6 February 2019 Kyle still owns at least 20,000 units of Miragen Therapeutics Inc stock.
You can see the complete history of Kyle Lefkoff stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
What's Kyle Lefkoff's mailing address?
Kyle's mailing address filed with the SEC is C/O BOULDER VENTURES, 1941 PEARL STREET, SUITE 300, BOULDER, CO, 80302.
Insiders trading at Miragen Therapeutics Inc
Over the last 8 years, insiders at Miragen Therapeutics Inc have traded over $636,110 worth of Miragen Therapeutics Inc stock and bought 1,041,411 units worth $5,368,137 . The most active insiders traders include Bennett S Lebow, Bruce Booth und Paul D Rubin. On average, Miragen Therapeutics Inc executives and independent directors trade stock every 91 days with the average trade being worth of $2,345,685. The most recent stock trade was executed by Global Master Fund Lp Logos on 9 November 2020, trading 476,667 units of MGEN stock currently worth $2,268,935.
What does Miragen Therapeutics Inc's logo look like?
Complete history of Kyle Lefkoff stock trades at Miragen Therapeutics Inc
Miragen Therapeutics Inc executives and stock owners
Miragen Therapeutics Inc executives and other stock owners filed with the SEC include:
-
Diana Escolar,
Chief Medical Officer -
Jason Leverone,
Principal Financial Officer, Principal Accounting Officer, Treasurer, Secretary -
Jeffrey Hatfield,
Independent Chairman of the Board -
Joseph Turner,
Independent Director -
Arlene Morris,
Independent Director -
Christopher Bowden,
Independent Director -
Tomas Kiselak,
Director -
Peter Harwin,
Director -
Lee Rauch,
Chief Executive Officer, Director -
Jonathan Violin,
President, Chief Operating Officer -
Bruce Booth,
Director -
Kyle Lefkoff,
Director -
Paul D Rubin,
EVP, Research & Development -
Adam Scott Levy,
Chief Business Officer -
Thomas E. Hughes,
Director -
Bennett S Lebow,
Director -
Global Master Fund Lp Logos,
10% owner -
John W Creecy,
Director -
Kevin Koch,
Director -
Funds Management Llc Fairmo...,
-
William Stuart Marshall,